Sight Sciences Announces 1,000th TearCare® Customer Installation
MENLO PARK, Calif., Jan. 26, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”) an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, announced today the 1,000th installation of its TearCare® System.
- MENLO PARK, Calif., Jan. 26, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”) an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, announced today the 1,000th installation of its TearCare® System.
- In 2019 Sight Sciences commercialized the TearCare® System with the knowledge that doctors, and patients were seeking improvements beyond those provided by current over the counter, prescription pharmaceutical, or in-office treatments for dry eye.
- Desired improvements included faster action, enduring results and, in the case of in-office treatment, a price point allowing more practices to equip their offices.
- Immediately following launch, Sight Sciences took the first step required to obtain access to coverage and payment for dry eye sufferers when the American Medical Association (AMA) granted a temporary procedural code specifically describing the open eye TearCare® procedure.